The global Parkinson’s disease treatment market is expected to grow at a CAGR of over 6% during the forecast period. The primary factors that drive the growth of the global Parkinson’s disease treatment industry include the increased incidences of Parkinson’s diseases across the globe. The increased prevalence of neurological disorders such as Parkinson’s and other diseases have encouraged the players to perform R&D activities for the development of novel and advanced treatment options. Also, various studies have been done to develop the total cure and increased effectiveness of the treatment of the disease.

Request a Free Report on Sample of Global Parkinson’s Disease Treatment Market @ https://www.omrglobal.com/request-sample/parkinsons-disease-treatment-market

In August 2019, a study was conducted by Johns Hopkins Medicine associated with Parkinson’s disease via deep brain stimulator (DBS) treatment. The DBS through electrical impulses jump starts the nerve cells that produce the dopamine to lessens muscle rigidity and tremors that are the basic symptoms of Parkinson’s disease. The research was performed on seven people to study the change in dopamine levels in the brain.

A full Report of Global Parkinson’s Disease Treatment Market Available at https://www.omrglobal.com/industry-reports/parkinsons-disease-treatment-market

The researchers performed PET (Positron Emission Tomography) scan on a patient with Parkinson’s disease taking dopamine increasing medications (levodopa), using a tracer for Vesicular Monoamine Transporter 2 (VMAT2). The scans showed that, as the dopamine levels in the brain increase with levodopa, VMAT2 levels decrease, and vice versa. The researchers found that, after DBS, patients having Parkinson’s disease had fewer tremors and less rigidity, and patients showed improvement in cognitive abilities and mood, with depression scores dropping by 40%.

Further, the global Parkinson’s disease treatment market has significant players operating in the industry and providing medications and surgical procedures globally. Some of the prominent players functioning in the global Parkinson’s disease treatment market Medtronic Plc, AbbVie Inc., Boehringer Ingelheim GmbH, GlaxoSmithKline Plc, Boston Scientific Corp., Cipla Inc., Mylan NV, Novartis International AG, Eli Lilly& Co., Pfizer Inc., and Teva Pharmaceutical Industries Ltd. among others. These players are significantly contributing to expanding the global Parkinson’s disease treatment market size during the forecast period.

Current Market Trends Covered in the market report:

• Increased spending on the healthcare R&D activities by the government and private organizations are positively affecting the Parkinson’s disease treatment market growth
• Deep Brain Stimulators (DBS) segment will account for significant growth in the market
• The novel innovations and product enhancements will be the key strategy adopted by the players
• The Asia-Pacific region will register a significant growth rate in Parkinson’s Disease Treatment market globally

Global Parkinson’s Disease Treatment Market – Segmentation

By Type

• Drugs
• Surgical Procedures

Segmentation by Region

North America

• United States
• Canada

Europe

• Germany
• United Kingdom
• France
• Spain
• Italy

Rest of Europe

• Asia-Pacific
• China
• Japan
• India
• Rest of Asia-Pacific

Rest of the World

• Middle East & Africa
• Latin America

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/parkinsons-disease-treatment-market

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

For More Information, Visit https://www.omrglobal.com/

Media Contact:

Company Name: Orion Market Research
Contact Person: Mr. AnuragTiwari
Email: [email protected]
Contact no: +1 646-755-7667, +91 780-304-0404